Ecolab, Inc.
ECL
$0.00
-1.95%
Ecolab Inc. is a global leader in providing cleaning, sanitation, and water management products and services. It holds a dominant market position across industrial, hospitality, healthcare, and life sciences sectors, leveraging a comprehensive portfolio and strong international presence.…
ECL
Ecolab, Inc.
$0.00
Investment Opinion: Should I buy ECL Today?
Based on a synthesis of the data, the objective assessment is a Hold. The company's fundamental strengths—market leadership, profitability, and cash flow—are undeniable. However, the current valuation is demanding, and the stock is in a corrective phase following a major, market-questioned acquisition. For new investors, it may be prudent to wait for clearer evidence of successful CoolIT integration or a more attractive entry point. Existing investors with a long-term horizon may hold, given the company's quality and new growth avenue, but should monitor execution closely.
Sign up to view all
ECL 12-Month Price Forecast
The analysis leans neutral due to the clash between high-quality fundamentals and a rich valuation amplified by acquisition-related uncertainty. The 12-month outlook is highly contingent on the market's perception of the CoolIT deal's success. The base case sees modest upside, but risks are skewed to the downside if execution falters.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ecolab, Inc.'s 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
11 analysts
Implied Upside
—
vs. current price
Analyst Count
11
covering this stock
Price Range
$0 - $0
Analyst target range
Wall Street analyst coverage for Ecolab is active, with 11 analysts providing estimates. The consensus estimated EPS for the upcoming period is $10.80, with a range from $10.60 to $11.03. Estimated revenue consensus is approximately $19.49 billion. Recent institutional ratings from firms like Baird (Outperform), JP Morgan (Overweight), and Jefferies (Buy) indicate a generally positive outlook, though specific price targets are not provided in the data.
Bulls vs Bears: ECL Investment Factors
Ecolab is a financially strong industry leader with a new growth catalyst in AI cooling, but its stock faces headwinds from a rich valuation and recent market skepticism about a major acquisition. The recent sharp correction has brought the price down from its highs, creating a more balanced risk/reward profile. The core business remains robust, but the stock's near-term performance hinges on successful integration of CoolIT and delivering earnings to match its premium multiple.
Bullish
- Dominant Market Position: Global leader in cleaning, sanitation, and water management across diverse, stable end markets.
- Strong Profitability Metrics: High ROE of 21.2% and net margin of 13.4% indicate efficient capital use and pricing power.
- Robust Free Cash Flow: $1.9B TTM FCF supports dividends, buybacks, and strategic acquisitions like CoolIT.
- Positive Analyst Sentiment: Major firms like Baird and JP Morgan maintain Outperform/Overweight ratings.
Bearish
- Elevated Valuation Multiples: Trailing P/E of 35.8 and forward P/E of 27.5 are high, demanding strong growth.
- Recent Sharp Price Correction: Stock down ~14% from 52-week high, underperforming S&P 500 by 8.5% over 1 month.
- Acquisition Execution Risk: $4.75B CoolIT deal is large; investor skepticism reflected in recent stock decline.
- Moderate Revenue Growth: Latest Q4 revenue grew 4.8% YoY, which may not justify premium valuation.
ECL Technical Analysis
The stock has experienced significant volatility over the past six months, with a notable decline from a peak near $309 in late February 2026 to a current price of $266.02. The 1-month performance shows a sharp decline of -13.73%, significantly underperforming the S&P 500, while the 3-month change is a modest gain of 1.33%, outperforming the broader market. The price action suggests a recent correction following a strong rally earlier in the year.
Short-term performance has been weak, with the stock falling over 13% in the past month. This decline coincides with a period of market weakness but represents a more pronounced drop. Over the last three months, the stock is up slightly, indicating the recent sell-off has erased most of the gains from a rally that peaked in late February.
The current price of $266.02 sits approximately 14% below its 52-week high of $309.27 and about 20% above its 52-week low of $221.62. This places the stock in the lower half of its yearly range. No RSI data is provided for the current position analysis.
Beta
1.02
1.02x market volatility
Max Drawdown
-16.8%
Largest decline past year
52-Week Range
$222-$309
Price range past year
Annual Return
+4.2%
Cumulative gain past year
| Period | ECL Return | S&P 500 |
|---|---|---|
| 1m | -11.5% | -4.3% |
| 3m | +0.6% | -4.0% |
| 6m | -4.5% | -2.0% |
| 1y | +4.2% | +22.2% |
| ytd | +0.6% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ECL Fundamental Analysis
Revenue in the latest quarter (Q4 2025) was $4.20 billion, representing a year-over-year growth of 4.8% from the same quarter in 2024. Net income for the quarter was $563.9 million, yielding a net margin of 13.4%, which shows improvement in profitability from the prior-year period. The company maintains a strong free cash flow of $1.90 billion on a trailing twelve-month basis.
Financial health appears stable with a debt-to-equity ratio of 0.97, indicating a balanced use of debt and equity financing. The current ratio is 1.08, suggesting adequate, though not excessive, short-term liquidity. Operating cash flow remains robust, supporting dividends, share repurchases, and strategic acquisitions.
Operational efficiency is solid, with a Return on Equity (ROE) of 21.24% and a Return on Assets (ROA) of 7.84%, indicating effective use of shareholder capital and company assets. The gross margin for the latest quarter was 44.0%, and the operating margin was 18.1%, reflecting healthy operational control.
Quarterly Revenue
$4.2B
2025-12
Revenue YoY Growth
+0.04%
YoY Comparison
Gross Margin
+0.44%
Latest Quarter
Free Cash Flow
$1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ECL Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 35.83, and the forward P/E is 27.48. These levels are elevated, suggesting the market prices in expectations for future earnings growth. The high P/E ratios reflect the company's premium positioning and stable cash flows.
Peer comparison data for industry averages is not available in the provided inputs. Other valuation metrics include a Price-to-Sales (P/S) ratio of 4.62 and an Enterprise Value-to-EBITDA (EV/EBITDA) ratio of 24.02. The negative PEG ratio of -26.62, based on trailing metrics, is not a reliable indicator due to likely calculation anomalies with earnings growth.
PE
35.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 25x~79x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.0x
Enterprise Value Multiple
Investment Risk Disclosure
Ecolab's primary risks are valuation-related and executional. The stock trades at elevated multiples (P/E of 35.8, EV/EBITDA of 24.0), making it vulnerable to earnings disappointments or a contraction in valuation premiums. The recent $4.75 billion acquisition of CoolIT introduces significant integration and execution risk; the market's immediate negative reaction suggests concerns over price and strategic pivot timing. Furthermore, the company operates in cyclical end-markets like hospitality and industrial manufacturing, which could see demand soften in an economic downturn, impacting its steady revenue growth.
Financial risks, while moderate, are present. A debt-to-equity ratio of 0.97 indicates a leveraged balance sheet, which the CoolIT acquisition will likely exacerbate, potentially increasing interest expense and limiting financial flexibility. Competitive pressures and the ability to pass on input cost inflation to maintain its healthy gross margins (~44%) are ongoing operational risks. The stock's high short ratio of 2.14 also indicates a notable level of bearish sentiment from some investors, which could amplify downside volatility.
FAQ
The key risks are: 1) Valuation Risk: High P/E requires sustained strong earnings growth. 2) Acquisition/Execution Risk: The $4.75B CoolIT deal must be integrated successfully. 3) Economic Cyclicality: Downturns could impact industrial and hospitality segments. 4) Financial Risk: Debt-to-equity of 0.97 could rise post-acquisition, increasing leverage. 5) Sentiment Risk: High short ratio (2.14) indicates bearish bets that can pressure the stock.
The 12-month outlook presents a range of scenarios. The base case (55% probability) sees the stock trading between $270 and $300, roughly in line with current levels and analyst expectations. The bull case (25%) could see a re-test of the 52-week high near $309, while the bear case (20%) could see a pullback toward the $240-$270 range if execution stumbles. The consensus hinges on the success of the CoolIT integration.
Based on traditional metrics, ECL appears overvalued. Its trailing P/E of 35.8 and forward P/E of 27.5 are high compared to its recent growth profile. The EV/EBITDA of 24.0 also suggests a premium valuation. The market is pricing in significant future growth, primarily from the new AI cooling segment, making the stock vulnerable if that growth is delayed or fails to materialize.
ECL is a high-quality company, but it is not an unequivocal 'good buy' at current levels. Its trailing P/E of 35.8 is demanding for its ~5% revenue growth rate. The recent major acquisition adds execution risk. A 'Hold' rating is more appropriate until there is evidence that earnings growth will accelerate to justify the valuation or the price corrects further.
ECL is more suitable for a long-term investment horizon. The company's durable business model and strategic growth initiatives, like the AI cooling segment, will take years to fully play out. Short-term volatility is likely due to valuation concerns and acquisition integration news. Patient investors can benefit from the company's market leadership and cash flows, while short-term traders face significant uncertainty.